Your session is about to expire
What is Mupirocin
Approved as Treatment by the FDA
Mupirocin, also called Bactroban, is approved by the FDA for 7 uses which include Bacterial infection due to streptococcus, group A and staphylococcus aurea colonization of the nasal passage .Effectiveness
When to interrupt dosage
The suggested dosage of Mupirocin is contingent upon the determined condition, such as Communicable Diseases, Bacterial Infections and staphylococcus aurea colonization of the nasal passage. The amount of dosage is subject to the technique of delivery (e.g. Ointment or Cream) specified in the table beneath.Warnings
Mupirocin ContraindicationsMupirocin Novel Uses: Which Conditions Have a Clinical Trial Featuring Mupirocin?
An active clinical trial is investigating the potential of Mupirocin in providing a remedy for Bacterial Infections, Impetigo and Communicable Diseases.Mupirocin Reviews: What are patients saying about Mupirocin?
Patient Q&A Section about mupirocin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is mupirocin ointment used for?
"Mupirocin topical cream is used to treat skin lesions that have become infected with specific bacteria. Mupirocin topical ointment is used to treat impetigo. This medicine works by killing bacteria or preventing their growth. You will need a prescription from your doctor to get this medicine."
When should you not use mupirocin?
"Do not apply this medication to skin that is damaged or broken, or around the eyes, nose, or mouth, unless your doctor tells you to. If it accidentally gets on these areas, rinse it off right away with plenty of water. If your condition does not improve within 3 to 5 days, tell your doctor."
Is mupirocin the same as Neosporin?
"No, mupirocin is not the same as Neosporin."
What kind of antibiotic is mupirocin?
"Mupirocin binds reversibly to bacterial isoleucyl-transfer RNA synthetase, thereby inhibiting protein synthesis. Mupirocin, which was formerly called pseudomonic acid A, is a topical antibiotic that is being researched for the treatment of impetigo and other superficial primary and secondary skin infections. Mupirocin (Bactroban, Beecham Laboratories) is currently formulated as a 2% ointment in a water-miscible polyethylene glycol base. Mupirocin binds reversibly to bacterial isoleucyl-transfer RNA synthetase, which inhibits protein synthesis."